Promis Diagnostics' EarlyTect BCD Receives FDA Breakthrough Device Designation for Bladder Cancer Detection
/PRNewswire/ -- Promis Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to...